OMG @ravanelli77 is bullish! Nice to see you positive Rav.. I know it's been a roller-coaster ride for us all and a long journey. We're at the pointy end now.. yes I agree with what you are saying. Pfizer definitely want this tech regardless. They will be willing to pay a lot more than 20.7 cents IMO. If the double blind study is positive next week it means we are very likely to obtain FDA clearance this would mean a much higher price than 20.7 cents IMO!!! This is basically a breakeven price for all of these sophisticated investors that took part in the two Capital raises ( only three in the company's history) prior to the 5.7 cent raise more recently...
Cheers
Red bar
- Forums
- ASX - By Stock
- RAP
- Ann: Increased Scheme Consideration from Pfizer
Ann: Increased Scheme Consideration from Pfizer, page-233
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online